(Q53395881)

13 May 2018

title

Interferon-alpha prevents selection of doxorubicin-resistant undifferentiated-androgen-insensitive metastatic human prostate cancer cells. (English)

1 reference

13 May 2018

7

Fidler IJ

1 reference

13 May 2018

author name string

Kuniyasu H

1

1 reference

13 May 2018

Yasui W

2

1 reference

13 May 2018

Pettaway CA

3

1 reference

13 May 2018

Yano S

4

1 reference

13 May 2018

Oue N

5

1 reference

13 May 2018

Tahara E

6

1 reference

13 May 2018

publication date

1 September 2001

1 reference

13 May 2018

published in

The Prostate

1 reference

13 May 2018

volume

49

1 reference

13 May 2018

issue

1

1 reference

13 May 2018

page(s)

19-29

1 reference

13 May 2018

cites work

Cancer statistics, 1999.

1 reference

Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens

21 January 2018

1 reference

Current chemotherapy and future directions in research for the treatment of advanced hormone-refractory prostate cancer

21 January 2018

1 reference

Biological determinants of cancer progression in men with prostate cancer.

21 January 2018

1 reference

Cadherins: a molecular family important in selective cell-cell adhesion

21 January 2018

1 reference

Cadherin cell adhesion receptors as a morphogenetic regulator

21 January 2018

1 reference

Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene

21 January 2018

1 reference

Loss of cytokeratin expression and formation of actin stress fibers in dedifferentiated MDCK-C7 cell lines

21 January 2018

1 reference

Regulation of the cytoskeleton in mesothelial cells: Reversible loss of keratin and increase in vimentin during rapid growth in culture

21 January 2018

1 reference

Loss of epithelial differentiation markers and acquisition of vimentin expression after xenograft with laminin-1 enhance migratory and invasive abilities of human colon cancer cells LoVo C5.

21 January 2018

1 reference

Different vimentin expression in two clones derived from a human colocarcinoma cell line (LoVo) showing different sensitivity to doxorubicin

21 January 2018

1 reference

Phase III trial of cyclophosphamide versus cyclophosphamide, doxorubicin, and methotrexate in hormone-refractory prostatic cancer. A Hoosier Oncology Group study

21 January 2018

1 reference

Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer

21 January 2018

1 reference

Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate

21 January 2018

1 reference

Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancer

21 January 2018

1 reference

Cytokine therapeutics: lessons from interferon alpha

21 January 2018

1 reference

Plakoglobin: a protein common to different kinds of intercellular adhering junctions

21 January 2018

1 reference

Acquired multicellular-mediated resistance to alkylating agents in cancer

21 January 2018

1 reference

Levels of expression of hRPB11, a core subassembly subunit of human RNA polymerase II, affect doxorubicin sensitivity and cellular differentiation.

21 January 2018

1 reference

Tumor-suppressor genes: news about the interferon connection

21 January 2018

1 reference

Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2

21 January 2018

1 reference

Eukaryotic initiation factor eIF2.

21 January 2018

1 reference

Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1.

21 January 2018

1 reference

Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system

21 January 2018

1 reference

Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells

21 January 2018

1 reference

IFNalpha induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells

21 January 2018

1 reference

p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells

21 January 2018

1 reference

Dedifferentiation of locally recurrent prostate cancer after radiation therapy. Evidence for tumor progression

21 January 2018

1 reference

Prostate specific antigen and gleason grade: an immunohistochemical study of prostate cancer

21 January 2018

1 reference

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia

21 January 2018

1 reference

Differential Cytokeratin Expression in Normal, Hyperplastic and Malignant Epithelial Cells From Human Prostate

21 January 2018

1 reference

Positive association between cytoskeletal changes, melanoma cell attachment and invasion in vitro.

21 January 2018

1 reference

Vimentin expression in cervical carcinomas: association with invasive and migratory potential

21 January 2018

1 reference

Vimentin-positive adenocarcinomas of the stomach: co-expression of vimentin and cytokeratin

21 January 2018

1 reference

Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer

21 January 2018

1 reference

Combined versus sequential chemo-endocrine therapy in advanced prostate cancer: final results of a randomized Southwest Oncology Group study

21 January 2018

1 reference

The apoptosis pathway triggered by the interferon-induced protein kinase PKR requires the third basic domain, initiates upstream of Bcl-2, and involves ICE-like proteases

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PROS.1114

1 reference

13 May 2018

1 reference

13 May 2018